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by 31% (5). Because stroke is a major cause of dementia, statins
must be considered potentially valuable agents for preventing
cognitive decline in patients with risk factors for atherosclerosis or
dementia.
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Does Inhaled Nitric Oxide Support the
Hemodynamic of Spontaneous Breathing
Patients With Cardiogenic Shock Related to
Right Ventricular Myocardial Infarction?
We read with great interest the echocardiographic study published
by Inglessis et al. (1) concerning hemodynamic effects of inhaled
nitric oxide (NO) in right ventricular myocardial infarction
(RVMI) and cardiogenic shock (CS). They found that inhaled NO
results in acute hemodynamic improvement when administered to
patients with RVMI and CS.
We have a major concern with these results. Indeed, although
10 of 13 patients were under positive pressure ventilation, the
investigators leave the reader with the feeling that inhaled NO
results in significant hemodynamic improvement and a reduction
of right to left shunting when administered to all types of patients.
In our opinion, we may expect that the observed NO effect
could not be shown in spontaneous breathing patients. Indeed, as
stated by the researchers, breathing NO is thought to increase
pulmonary venous return and left ventricular filling pressure when
cardiac output is decreased (2). Because positive pressure ventila-
tion acts as a circulatory pump (3) and decreases left ventricular
transmural pressure, acute left ventricular failure may occur when
the lungs are not mechanically assisted.
In this setting, we suggest to Inglessis et al. (1) not to extend
their conclusions regarding the hemodynamic inhaled NO effects
to spontaneous ventilated patients with acute RVMI and CS.
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REPLY
We thank Dr. Bendjelid for his interest in our work (1). We agree
that the majority of our patients were studied while undergoing
positive pressure ventilation. As only three patients in our study
population did not require mechanical ventilation, our ability to
extrapolate our results to patients with right ventricular myocardial
infarction (RVMI) not receiving mechanical ventilation is limited.
Nonetheless, there was no difference in the improvement in cardiac
index observed between those patients breathing nitric oxide (NO)
who were mechanically ventilated and those who were not.
Dr. Bendjelid also raises the concern that positive pressure
ventilation may act to prevent the development of acute left
ventricular (LV) failure that may occur during NO inhalation, and
that LV failure may arise in nonventilated patients. Left ventricular
filling pressures have been found to increase during NO inhalation
in patients with severe LV systolic dysfunction (2,3). The RVMI
patients in our study had primarily RV dysfunction, and the degree
of LV dysfunction was not as severe as in those patients in whom
the pulmonary capillary wedge pressure (PCWP) has been re-
ported to increase during NO inhalation. Furthermore, we ex-
cluded patients with a PCWP 25 mm Hg from study. In the
three nonventilated RVMI patients in our study, we did not
observe an increase in their PCWP while they were breathing NO
for 10 min.
In future studies of the effects of sustained NO inhalation in
RVMI patients, it will be important to observe the hemodynamic
effects of this agent in patients who receive positive pressure
ventilation as well as those who do not. Patients with severe LV
systolic function should be monitored carefully during chronic NO
inhalation because of the possibility of their developing pulmonary
venous hypertension.
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